Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “The United States of America”

3,063 pharma patents match "The United States of America" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 3,063
Index total 30,257
Page 8 / 128

Quick answer

This filtered view shows 3,063 pharmaceutical patents matching "The United States of America" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

3,063 results for “The United States of America” · 30,257 patents in full index Clear search

  1. US 11780931

    CD47 targeted therapies for the treatment of infectious disease

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 10, 2023 · Expires Oct 5, 2043

    granted

  2. US 11782065

    Kits and methods for prediction and treatment of preeclampsia

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 10, 2023 · Expires Oct 5, 2043

    granted

  3. US 11779570

    Method for inhibiting dengue virus infection

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 10, 2023 · Expires Oct 5, 2043

    granted

  4. US 11779601

    Diagnostic methods for T cell therapy

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 10, 2023 · Expires Oct 5, 2043

    granted

  5. US 11779603

    HERV-E reactive T cell receptors and methods of use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 10, 2023 · Expires Oct 5, 2043

    granted

  6. US 11771737

    Treating or preventing adverse liver conditions

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 3, 2023 · Expires Sep 28, 2043

    granted

  7. US 11766476

    Genomic deletion in African swine fever vaccine allowing efficient growth in stable cell lines

    The United States of America, as represented by the Secretary of Agriculture · Granted Sep 26, 2023 · Expires Sep 21, 2043

    granted

  8. US 11760790

    Neutralizing antibodies to HIV-1 Env and their use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Sep 19, 2023 · Expires Sep 14, 2043

    granted

  9. US 11760794

    Neutralizing antibodies to plasmodium falciparum circumsporozoite protein and their use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Sep 19, 2023 · Expires Sep 14, 2043

    granted

  10. US 11759513

    Human rotavirus G9P[6] strain and use as a vaccine

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Sep 19, 2023 · Expires Sep 14, 2043

    granted

  11. US 11753408

    Compounds and method for blocking transmission of malarial parasite

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Sep 12, 2023 · Expires Sep 7, 2043

    granted

  12. US 11752138

    Treating primary or idiopathic hyperoxaluria with small molecule inhibitors of lactate dehydrogenase

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Sep 12, 2023 · Expires Sep 7, 2043

    granted

  13. US 11753627

    Dengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3′-UTR of dengue types 1,2,3, and 4, or antigenic chimeric dengue viruses 1,2,3, and 4

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Sep 12, 2023 · Expires Sep 7, 2043

    granted

  14. US 11746335

    Development of dengue virus vaccine components

    The Government of the United States of American, as represented by the Secretary, Department of Health and Human Services · Granted Sep 5, 2023 · Expires Aug 31, 2043

    granted

  15. US 11744834

    Metal-porphyrin complexes for the inactivation of the biological activity of opioids

    The Government of the United States of America, as represented by the Secretary of the Navy · Granted Sep 5, 2023 · Expires Aug 31, 2043

    granted

  16. US 11739137

    Single domain antibodies to SARS-CoV-2 nucleocapsid protein

    The Government of the United States of America, as represented by the Secretary of the Navy · Granted Aug 29, 2023 · Expires Aug 24, 2043

    granted

  17. US 11739063

    DREADD actuators

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 29, 2023 · Expires Aug 24, 2043

    granted

  18. US 11733191

    Closed-loop controlled chemical apparatus

    Government of the United States of America, as represented by the Secretary of Commerce · Granted Aug 22, 2023 · Expires Aug 17, 2043

    granted

  19. US 11723923

    Methods of preparing T cells for T cell therapy

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 15, 2023 · Expires Aug 10, 2043

    granted

  20. US 11723943

    Therapeutic use of chardonnay seed products

    The United States of America, as represented by the Secretary of Agriculture · Granted Aug 15, 2023 · Expires Aug 10, 2043

    granted

  21. US 11725248

    Evaluation of mantle cell lymphoma and methods related thereto

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 15, 2023 · Expires Aug 10, 2043

    granted

  22. US 11723362

    Broad-spectrum synergistic antimicrobial compositions

    The United States of America, as represented by the Secretary of Agriculture · Granted Aug 15, 2023 · Expires Aug 10, 2043

    granted

  23. US 11718647

    Virus-like particles and methods of use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 8, 2023 · Expires Aug 3, 2043

    granted

  24. US 11702417

    Compounds for improving mRNA splicing

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jul 18, 2023 · Expires Jul 13, 2043

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.